[Treatment of malignant lymphoma with extranodal lesions--indications and timing for local therapies].
Kinoshita
T
T
Kagami
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008223:Lymphoma / Q000473:pathology / Q000628:therapy; D008297:Male; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D011878:Radiotherapy; D013274:Stomach Neoplasms / Q000628:therapy; D013736:Testicular Neoplasms / Q000628:therapy; D013964:Thyroid Neoplasms / Q000628:therapy; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone